热门资讯> 正文

Collegium宣布1.5亿美元股票回购计划

2025-07-07 20:08

Collegium (NASDAQ:COLL) has authorized a new share repurchase program to repurchase up to $150 million in common stock through December 31, 2026, replacing previous $150 million share repurchase program authorized in January 2024 which expired on June 30, 2025, which had $65 million remaining under the program.
As of March 31, 2025, Collegium had approximately 32.1 million shares outstanding.
Source: Press Release

More on Collegium Pharmaceutical

Collegium Pharmaceutical: Stock Deserves A 'Buy' Call On Undervaluation Of ADHD Drug
Collegium Pharmaceutical, Inc. 2025 Q1 - Results - Earnings Call Presentation
Collegium Pharmaceutical, Inc. (COLL) Q1 2025 Earnings Call Transcript
Collegium Pharmaceutical enters into accelerated share repurchase agreement
Collegium pharmaceutical targets $135M in Jornay PM revenue for 2025 amid sales force expansion

推荐文章

风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。